Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-020363
Filing Date
2025-02-14
Accepted
2025-02-14 06:22:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 13161
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 15863
  Complete submission text file 0000950170-25-020363.txt   37097
Mailing Address 444 WEST LAKE STREET 50TH FLOOR CHICAGO IL 60606
Business Address 444 WEST LAKE STREET 50TH FLOOR CHICAGO IL 60606 312.499.2999
BALYASNY ASSET MANAGEMENT L.P. (Filed by) CIK: 0001218710 (see all company filings)

EIN.: 364472709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Subject) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90188 | Film No.: 25623002
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)